Cited by 251Schizophrenia research and treatmentPsychological Testing and AssessmentMental Health and Psychiatry

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study

Open access

Kern, Robert S., Gold, James M., Dickinson, Dwight, Green, Michael F., Nuechterlein, Keith H., Baade, Lyle E., Keefe, Richard S.E., Mesholam-Gately, Raquelle I., Seidman, Larry J., Lee, Cathy, Sugar, Catherine A., Marder, Stephen R.·2011·Schizophrenia Research

DOI 10.1016/j.schres.2010.11.008PMC PMC3050090

Open this paper in CoChat — free account

Abstract

The MATRICS Psychometric and Standardization Study was conducted as a final stage in the development of the MATRICS Consensus Cognitive Battery (MCCB). The study included 176 persons with schizophrenia or schizoaffective disorder and 300 community residents. Data were analyzed to examine the cognitive profile of clinically stable schizophrenia patients on the MCCB. Secondarily, the data were analyzed to identify which combination of cognitive domains and corresponding cut-off scores best discriminated patients from community residents, and patients competitively employed vs. those not. Raw scores on the ten MCCB tests were entered into the MCCB scoring program which provided age- and gender-corrected T-scores on seven cognitive domains. To test for between-group differences, we conducted a 2 (group)×7 (cognitive domain) MANOVA with follow-up independent t-tests on the individual domains. Classification and regression trees (CART) were used for the discrimination analyses. Examination of patient T-scores across the seven cognitive domains revealed a relatively compact profile with T-scores ranging from 33.4 for speed of processing to 39.3 for reasoning and problem-solving. Speed of processing and social cognition best distinguished individuals with schizophrenia from community residents; speed of processing along with visual learning and attention/vigilance optimally distinguished patients competitively employed from those who were not. The cognitive profile findings provide a standard to which future studies can compare results from other schizophrenia samples and related disorders; the classification results point to specific areas and levels of cognitive impairment that may advance work rehabilitation efforts.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.schres.2010.11.008

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,867
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
Untitled work
(1995) · Cited by 2,809
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., Essock, S., Fenton, W. S., Frese, F. J., Gold, J. M., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010042 · Cited by 2,342
Neuropsychological Assessment
Benton, A. (1994) · Annual Review of Psychology · doi:10.1146/annurev.psych.45.1.1 · Cited by 2,298
Identification of separable cognitive factors in schizophrenia
Nuechterlein, K. H., Barch, D. M., Gold, J. M., Goldberg, T. E., Green, M. F., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.007 · Cited by 1,304
The Social Functioning Scale the Development and Validation of a New Scale of Social Adjustment for use in Family Intervention Programmes with Schizophrenic Patients
Birchwood, M., Smith, J., Cochrane, R., Wetton, S., & Copestake, S. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.6.853 · Cited by 1,157
Neurocognition in first-episode schizophrenia: a meta-analytic review.
Mesholam-Gately, R. I., Giuliano, A. J., Goff, K. P., Faraone, S. V., & Seidman, L. J. (2009) · Neuropsychology · doi:10.1037/a0014708 · Cited by 1,130
Memory Impairment in Schizophrenia: A Meta-Analysis
Aleman, A., Hijman, R., de Haan, E. H. F., & Kahn, R. S. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1358 · Cited by 1,093

Show all 32 references

Research works printed but not linked: 1

Lukoff, 1986, Appendix A: manual for the expanded brief psychiatric rating scale (BPRS), Schizophr. Bull., 12, 594

Sorted by citations

Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective
Sheffield, J. M., Karcher, N. R., & Barch, D. M. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9388-2 · Cited by 466
Metagenome-wide association of gut microbiome features for schizophrenia
Zhu, F., Ju, Y., Wang, W., Wang, Q., Guo, R., Ma, Q., Sun, Q., Fan, Y., Xie, Y., Yang, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15457-9 · Cited by 409
Auditory dysfunction in schizophrenia: integrating clinical and basic features
Javitt, D. C., & Sweet, R. A. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4002 · Cited by 377
The clinical characterization of the patient with primary psychosis aimed at personalization of management
Maj, M., van Os, J., De Hert, M., Gaebel, W., Galderisi, S., Green, M. F., Guloksuz, S., Harvey, P. D., Jones, P. B., Malaspina, D., et al. (2021) · World Psychiatry · doi:10.1002/wps.20809 · Cited by 285
Cognitive emotion regulation strategies, alexithymia and dissociation in schizophrenia, a review and meta-analysis
O’Driscoll, C., Laing, J., & Mason, O. J. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.07.002 · Cited by 302
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia
Carbon, M., & Correll, C. U. (2014) · CNS Spectrums · doi:10.1017/s1092852914000601 · Cited by 281
Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations
McCleery, A., & Nuechterlein, K. H. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.3/amccleery · Cited by 239
The Impact of Aerobic Exercise on Brain-Derived Neurotrophic Factor and Neurocognition in Individuals With Schizophrenia: A Single-Blind, Randomized Clinical Trial
Kimhy, D., Vakhrusheva, J., Bartels, M. N., Armstrong, H. F., Ballon, J. S., Khan, S., Chang, R. W., Hansen, M. C., Ayanruoh, L., Lister, A., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv022 · Cited by 207
Fronto-parietal and cingulo-opercular network integrity and cognition in health and schizophrenia
Sheffield, J. M., Repovš, G., Harms, M. P., Carter, C. S., Gold, J. M., MacDonald, A. W., Ragland, J. D., Silverstein, S. M., Godwin, D., & Barch, D. M. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.05.006 · Cited by 193
Effects of transcranial direct current stimulation (tDCS) on cognition, symptoms, and smoking in schizophrenia: A randomized controlled study
Smith, R. C., Boules, S., Mattiuz, S., Youssef, M., Tobe, R. H., Sershen, H. W., Lajtha, Á., Nolan, K. A., Amiaz, R., & Davis, J. M. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.011 · Cited by 198
The MATRICS Consensus Cognitive Battery (MCCB): Clinical and cognitive correlates
August, S. M., Kiwanuka, J. N., McMahon, R. P., & Gold, J. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.10.015 · Cited by 171
Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia
Green, M. F., Schooler, N. R., Kern, R. S., Frese, F. J., Granberry, W., Harvey, P. D., Karson, C. N., Peters, N., Stewart, M., Seidman, L. J., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10030414 · Cited by 159
Assessing everyday functioning in schizophrenia: Not all informants seem equally informative
Sabbag, S. A., Twamley, E. M., Vella, L., Heaton, R. K., Patterson, T. L., & Harvey, P. D. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.003 · Cited by 156
Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?
Keefe, R. S. E., Buchanan, R. W., Marder, S. R., Schooler, N. R., Dugar, A., Zivkov, M., & Stewart, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr153 · Cited by 138
The relevance of cognitive emotion regulation to psychotic symptoms – A systematic review and meta-analysis
Ludwig, L., Werner, D., & Lincoln, T. M. (2019) · Clinical Psychology Review · doi:10.1016/j.cpr.2019.101746 · Cited by 147
Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study
Fleischhacker, W. W., Podhorná, J., Groeschl, M., Hake, S., Zhao, Y., Huang, S., Keefe, R. S. E., Desch, M., Brenner, R., Walling, D. P., et al. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30513-7 · Cited by 137
The neural basis of theory of mind and its relationship to social functioning and social anhedonia in individuals with schizophrenia
Dodell-Feder, D., Tully, L. M., Lincoln, S. H., & Hooker, C. I. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.11.006 · Cited by 119
Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment
McCleery, A., Ventura, J., Kern, R. S., Subotnik, K. L., Gretchen‐Doorly, D., Green, M. F., Hellemann, G., & Nuechterlein, K. H. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.039 · Cited by 125
Reading Deficits in Schizophrenia and Individuals at High Clinical Risk: Relationship to Sensory Function, Course of Illness, and Psychosocial Outcome
Revheim, N., Corcoran, C. M., Dias, E. C., Hellmann, E., Martı́nez, A., Butler, P. D., Lehrfeld, J. M., DiCostanzo, J., Albert, J., & Javitt, D. C. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13091196 · Cited by 116
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
Javitt, D. C., Buchanan, R. W., Keefe, R. S. E., Kern, R. S., McMahon, R. P., Green, M. F., Lieberman, J. A., GOFF, D. C., Csernansky, J. G., McEvoy, J. P., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.001 · Cited by 118
Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia
Vesterager, L., Christensen, T. Ø., Olsen, B. B., Krarup, G., Melau, M., Forchhammer, H. B., & Nordentoft, M. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.08.023 · Cited by 97
Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial
Lin, C.-Y., Liang, S.-Y., Chang, Y., Ting, S.-Y., Kao, C.-L., Wu, Y., Tsai, G. E., & Lane, H. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1117654 · Cited by 97
Adapting Social Neuroscience Measures for Schizophrenia Clinical Trials, Part 2: Trolling the Depths of Psychometric Properties
Kern, R. S., Penn, D. L., Lee, J., Horan, W. P., Reise, S. P., Ochsner, K. N., Marder, S. R., & Green, M. F. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt127 · Cited by 95
Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia
Burton, C. Z., Vella, L., Harvey, P. D., Patterson, T. L., Heaton, R. K., & Twamley, E. W. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.026 · Cited by 95
Mobile Phone and Smartphone Use by People With Serious Mental Illness
Young, A. S., Cohen, A. N., Niv, N., Nowlin-Finch, N., Oberman, R. S., Olmos‐Ochoa, T. T., Goldberg, R. W., & Whelan, F. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201900203 · Cited by 86
An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder
Rheenen, T. E. V., & Rossell, S. L. (2013) · Bipolar Disorders · doi:10.1111/bdi.12134 · Cited by 85
The efficacy of computerized cognitive drill and practice training for patients with a schizophrenia-spectrum disorder: A meta-analysis
Prikken, M., Konings, M. J., Lei, W. U., Begemann, M., & Sommer, I. E. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.07.034 · Cited by 84
Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients
Zhang, B., Han, M., Tan, S., Yang, F. D., Tan, Y., Jiang, S., Zhang, X., & Huang, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-12027-w · Cited by 84
Stable Cognitive Deficits in Schizophrenia Patients With Comorbid Obsessive-Compulsive Symptoms: A 12-Month Longitudinal Study
Schirmbeck, F. N., Rausch, F., Englisch, S., Eifler, S., Esslinger, C., Meyer‐Lindenberg, A., & Zink, M. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs123 · Cited by 78
Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process
Mandal, P. K., Gaur, S., Roy, R. G., Samkaria, A., Ingole, R., & Goel, A. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00420 · Cited by 78
Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design
Burdick, K. E., Ketter, T. A., Goldberg, J. F., & Calabrese, J. R. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14cs09399 · Cited by 76
Attention/vigilance in schizophrenia: Performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS)
Nuechterlein, K. H., Green, M. F., Calkins, M. E., Greenwood, T. A., Gur, R. E., Gur, R. C., Lazzeroni, L. C., Light, G. A., Radant, A. D., Seidman, L. J., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.017 · Cited by 80
Working Memory Impairment Across Psychotic disorders
Gold, J. M., Barch, D. M., Feuerstahler, L. M., Carter, C. S., MacDonald, A. W., Ragland, J. D., Silverstein, S. M., Strauss, M. E., & Luck, S. J. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby134 · Cited by 71
MEASURING COGNITIVE FUNCTION IN MDD: EMERGING ASSESSMENT TOOLS
Russo, M., Mahon, K., & Burdick, K. E. (2014) · Depression and Anxiety · doi:10.1002/da.22297 · Cited by 73
Amplitude of low-frequency fluctuation (ALFF) may be associated with cognitive impairment in schizophrenia: a correlation study
Wang, P., Yang, J., Yin, Z., Duan, J., Zhang, R., Sun, J., Xu, Y., Liu, L., Chen, X., Li, H., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-018-1992-4 · Cited by 71
The Impact of Aging, Cognition, and Symptoms on Functional Competence in Individuals With Schizophrenia Across the Lifespan
Kalache, S. M., Mulsant, B. H., Davies, S., Liu, A. Y., Voineskos, A. N., Butters, M. A., Miranda, D., Menon, M., Kern, R. S., & Rajji, T. K. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu114 · Cited by 67
An ecologically valid performance-based social functioning assessment battery for schizophrenia
Shi, C., He, Y., Cheung, E. F. C., Yu, X., & Chan, R. C. K. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.09.023 · Cited by 62
Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia
Koola, M. M., Buchanan, R. W., Pillai, A., Aitchison, K. J., Weinberger, D. R., Aaronson, S. T., & Dickerson, F. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.04.037 · Cited by 63
Neurophysiologic measures of target engagement predict response to auditory-based cognitive training in treatment refractory schizophrenia
Hochberger, W. C., Joshi, Y. B., Thomas, M. L., Zhang, W., Bismark, A. W., Treichler, E. B. H., Tarasenko, M. A., Nungaray, J. A., Sprock, J., Cardoso, L., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0256-9 · Cited by 62
Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population
Wu, J. Q., Chen, D. C., Tan, Y., Xiu, M. H., Yang, F. D., Soares, J. C., & Zhang, X. Y. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.042 · Cited by 58
Personalised treatment for cognitive dysfunction in individuals with schizophrenia spectrum disorders
Medalia, A. A., Saperstein, A. M., Hansen, M. C., & Lee, S. (2016) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2016.1189341 · Cited by 57
The 5% difference: early sensory processing predicts sarcasm perception in schizophrenia and schizo-affective disorder
Kantrowitz, J. T., Hoptman, M. J., Leitman, D. I., Silipo, G., & Javitt, D. C. (2014) · Psychological Medicine · doi:10.1017/s0033291713000834 · Cited by 56
Efference Copy Failure during Smooth Pursuit Eye Movements in Schizophrenia
Spering, M., Dias, E. C., Sanchez, J. L., Schütz, A. C., & Javitt, D. C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0578-13.2013 · Cited by 61
The neuropsychology and neurobiology of late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: A critical review
Assche, L. V., Morrens, M., Luyten, P., de Ven, L. V., & Vandenbulcke, M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.024 · Cited by 60
Do cognitive deficits predict negative emotionality and aggression in schizophrenia?
Ahmed, A. O., Richardson, J., Buckner, A., Romanoff, S., Feder, M. R., Oragunye, N., Illnicki, A., Bhat, I., Hoptman, M. J., & Lindenmayer, J. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.11.003 · Cited by 59
Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives
Mucci, A., Galderisi, S., Green, M. F., Nuechterlein, K. H., Rucci, P., Gibertoni, D., Rossi, A., Rocca, P., Bertolino, A., Bucci, P., et al. (2017) · Psychological Medicine · doi:10.1017/s0033291717002902 · Cited by 54
Virtual reality functional capacity assessment in schizophrenia: Preliminary data regarding feasibility and correlations with cognitive and functional capacity performance
Ruse, S. A., Harvey, P. D., Davis, V. G., Atkins, A. S., Fox, K. H., & Keefe, R. S. E. (2014) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2014.01.004 · Cited by 52
Non-Invasive Brain Stimulation Does Not Improve Working Memory in Schizophrenia: A Meta-Analysis of Randomised Controlled Trials
Sloan, N. P., Byrne, L. K., Enticott, P. G., & Lum, J. A. G. (2020) · Neuropsychology Review · doi:10.1007/s11065-020-09454-4 · Cited by 52
Developing a Cognitive Training Strategy for First-Episode Schizophrenia: Integrating Bottom-Up and Top-Down Approaches
Nuechterlein, K. H., Ventura, J., Subotnik, K. L., Hayata, J. N., Medalia, A. A., & Bell, M. D. (2014) · American Journal of Psychiatric Rehabilitation · doi:10.1080/15487768.2014.935674 · Cited by 53
Age-Related Increase in the Number of Oligodendrocytes Is Dysregulated in Schizophrenia and Mood Disorders
Vm, V., & Uranova, N. A. (2011) · Schizophrenia Research and Treatment · doi:10.1155/2011/174689 · Cited by 51
Common and specific cognitive deficits in schizophrenia: relationships to function
Sheffield, J. M., Gold, J. M., Strauss, M. E., Carter, C. S., MacDonald, A. W., Ragland, J. D., Silverstein, S. M., & Barch, D. M. (2013) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-013-0211-5 · Cited by 53
Aerobic Exercise in People with Schizophrenia: Neural and Neurocognitive Benefits
Vakhrusheva, J., Marino, B., Stroup, T. S., & Kimhy, D. (2016) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-016-0077-2 · Cited by 53
A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis
Chaudhry, I. B., Husain, M. O., Khoso, A. B., Husain, M. I., Buch, M. H., Kiran, T., Fu, B., Bassett, P., Qurashi, I., Rahman, R. U., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01095-8 · Cited by 50
Neuropsychological profile in adult schizophrenia measured with the CMINDS
van Erp, T. G. M., Preda, A., Turner, J. A., Callahan, S., Calhoun, V. D., Bustillo, J., Lim, K. O., Mueller, B. A., Brown, G. G., Vaidya, J. G., et al. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.10.028 · Cited by 53
Effects of transcranial direct current stimulation on working memory and negative symptoms in schizophrenia: a phase II randomized sham-controlled trial
Gomes, J. S., Trevizol, A. P., Ducos, D. V., Gadelha, A., Ortiz, B. B., Fonseca, A. O., Akiba, H. T., de Azevedo, C. C., Guimarães, L. S. P., Shiozawa, P., et al. (2018) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2018.02.003 · Cited by 48
Measuring Cognition in Bipolar Disorder with Psychosis Using the MATRICS Consensus Cognitive Battery
Sperry, S. H., O’Connor, L. K., Öngür, D., Cohen, B. M., Keshavan, M. S., & Lewandowski, K. E. (2015) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617715000442 · Cited by 47
Mindfulness-Based Interventions for In-Patients With Schizophrenia Spectrum Disorders—A Qualitative Approach
Böge, K., Karadza, A., Fuchs, L. M., Ehlen, F., Ta, T. M. T., Thomas, N., Bajbouj, M., & Hahn, E. W. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00600 · Cited by 53
Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB)
McCleery, A., Green, M. F., Hellemann, G., Baade, L. E., Gold, J. M., Keefe, R. S. E., Kern, R. S., Mesholam-Gately, R. I., Seidman, L. J., Subotnik, K. L., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715000641 · Cited by 48
Neural oscillatory deficits in schizophrenia predict behavioral and neurocognitive impairments
Martı́nez, A., Gaspar, P. A., Hillyard, S. A., Bickel, S., Lakatos, P., Dias, E. C., & Javitt, D. C. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2015.00371 · Cited by 44
A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: A three-center double-blind placebo-controlled study
Koychev, I. G., McMullen, K., Lees, J., Dadhiwala, R., Grayson, L., Perry, C., Schmechtig, A., Walters, J., Craig, K. J., Dawson, G. R., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.10.005 · Cited by 42
N-methyl-d-aspartate-type glutamate receptor modulators and related medications for the enhancement of auditory system plasticity in schizophrenia
Kantrowitz, J. T. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.003 · Cited by 40
Unveiling the Associations between EEG Indices and Cognitive Deficits in Schizophrenia-Spectrum Disorders: A Systematic Review
Perrottelli, A., Giordano, G. M., Brando, F., Giuliani, L., Pezzella, P., Mucci, A., & Galderisi, S. (2022) · Diagnostics · doi:10.3390/diagnostics12092193 · Cited by 44
Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia
Giordano, G. M., Pezzella, P., Mucci, A., Austin, S. F., Erfurth, A., Glenthoj, B. Y., Hofer, A., Hubeňák, J., Libiger, J., Melle, I. S., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1333711 · Cited by 45
Aberrant activity and connectivity of the posterior superior temporal sulcus during social cognition in schizophrenia
Mier, D. U., Eisenacher, S., Rausch, F., Englisch, S., Gerchen, M. F., Zamoscik, V., Meyer‐Lindenberg, A., Zink, M., & Kirsch, P. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0737-y · Cited by 38
Age or age at onset? Which of them really matters for neuro and social cognition in schizophrenia?
Linke, M., Jankowski, K. S., Ciołkiewicz, A., Jędrasik-Styła, M., Parnowska, D., Gruszka, A., Denisiuk, M., Jarema, M., & Wichniak, A. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.024 · Cited by 38
The MATRICS Consensus Cognitive Battery (MCCB): Performance and functional correlates
Lystad, J. U., Falkum, E., Mohn, C., Haaland, V. Ø., Bull, H. C., Evensen, S., Rund, B. R., & Ueland, T. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.08.060 · Cited by 37
Clinical subtypes that predict conversion to psychosis: A canonical correlation analysis study from the ShangHai At Risk for Psychosis program
Zhang, T., Tang, X., Li, H., Woodberry, K. A., Kline, E. R., Xu, L., Cui, H., Tang, Y., Wei, Y., Li, C., et al. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419872248 · Cited by 38
Cognitive profiles in persons with chronic schizophrenia
Dawes, S. E., Jeste, D. V., & Palmer, B. W. (2011) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2011.578569 · Cited by 35
The effects of acute nicotine administration on cognitive and early sensory processes in schizophrenia: a systematic review
Dondé, C., Brunelin, J., Mondino, M., Cellard, C., Rolland, B., & Haesebaert, F. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.07.035 · Cited by 34
Lower cholinergic basal forebrain volumes link with cognitive difficulties in schizophrenia
Avram, M., Grothe, M. J., Meinhold, L., Leucht, C., Leucht, S., Borgwardt, S., Brandl, F., & Sorg, C. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01070-x · Cited by 35
Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in schizophrenia patients: a systematic review and meta-analysis
Khaity, A. M., Al-dardery, N. M., Albakri, K. A., Abdelwahab, O. A., Hefnawy, M. T., Yousef, Y. S. A. H., Taha, R. E. W., Swed, S., Hafez, W., Hurlemann, R., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1153648 · Cited by 35
Factors Associated With Premature Exits From Supported Housing
Gabrielian, S. E., Burns, A. V., Nanda, N., Hellemann, G., Kane, V. R., & Young, A. S. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400311 · Cited by 33
Effects of cognitive remediation on cognitive and social functions in individuals with schizophrenia
Katsumi, A., Hoshino, H., Fujimoto, S., Yabe, H., Ikebuchi, E., Nakagome, K., & Niwa, S. (2017) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2017.1409639 · Cited by 34
What is the optimal neuropsychological test battery for schizophrenia in China?
Shi, C., Kang, L., Yao, S., Ma, Y., Li, T., Liang, Y., Zhang, C., Xu, Y., Shi, J., Xu, X., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.034 · Cited by 33
Calculating individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis: findings from ShangHai At Risk for Psychosis (SHARP) program
Zhang, T., Xu, L., Li, H., Woodberry, K. A., Kline, E. R., Jiang, J., Cui, H., Tang, Y., Tang, X., Wei, Y., et al. (2019) · Psychological Medicine · doi:10.1017/s003329171900360x · Cited by 34
Relationships between abnormal neural activities and cognitive impairments in patients with drug-naive first-episode schizophrenia
Yan, W., Zhang, R., Zhou, M., Lu, S., Li, W., Xie, S., & Zhang, N. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02692-z · Cited by 33
Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats
de Bruin, N. M. W. J., Drimmelen, M. V., Kops, M. S., van Elk, J., de Wetering, M. M.-V., & Schwienbacher, I. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.035 · Cited by 34
High-intensity interval training and active video gaming improve neurocognition in schizophrenia: a randomized controlled trial
Bang-Kittilsen, G., Egeland, J., Holmen, T. L., Bigseth, T. T., Andersen, E., Mordal, J., Ulleberg, P., & Engh, J. A. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01200-4 · Cited by 32
Factors Affecting Exits From Homelessness Among Persons With Serious Mental Illness and Substance Use Disorders
Gabrielian, S. E., Bromley, E., Hellemann, G., Kern, R. S., Goldenson, N. I., Danley, M. E., & Young, A. S. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09229 · Cited by 31
Changing facial affect recognition in schizophrenia: Effects of training on brain dynamics
Popova, P., Popov, T. G., Wienbruch, C., Carolus, A. M., Miller, G. A., & Rockstroh, B. S. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.08.026 · Cited by 30
Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning
Ventura, J., Welikson, T., Ered, A., Subotnik, K. L., Keefe, R. S. E., Hellemann, G., & Nuechterlein, K. H. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12831 · Cited by 31
The Brazilian standardization of the MATRICS consensus cognitive battery (MCCB): Psychometric study
Fonseca, A. O., Berberian, A. D. A., de Meneses-Gaya, C., Gadelha, A., Vicente, M. O., Nuechterlein, K. H., Bressan, R. A., & Lacerda, A. L. T. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.006 · Cited by 30
The MATRICS Consensus Cognitive Battery: An Update
Nuechterlein, K. H., Green, M. F., & Kern, R. S. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_395 · Cited by 29
Cognition and gut microbiota in schizophrenia spectrum and mood disorders: A systematic review
Frileux, S., Boltri, M., Dore, J. M., Leboyer, M., & Roux, P. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105722 · Cited by 27
Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058
Sehatpour, P., Javitt, D. C., Baun, H. M. D., Carlson, M., Beloborodova, A. V., Margolin, D. H., Carlton, M. B. L., Brice, N., & Kantrowitz, J. T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01170-8 · Cited by 27
The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning
Rodríguez–Jiménez, R., Dompablo, M., Bagney, A., Santabárbara, J., Aparicio, A. I., Torío, I., Moreno-Ortega, M., López‐Antón, R., Lobo, A., Kern, R. S., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.09.013 · Cited by 28
The Impact of Anticholinergic Burden on Functional Capacity in Persons With Schizophrenia Across the Adult Life Span
Khan, W. U., Ghazala, Z., Brooks, H. J., Subramaniam, P., Mulsant, B. H., Kumar, S., Voineskos, A. N., Blumberger, D. M., Kern, R. S., & Rajji, T. K. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa093 · Cited by 27
Neurocognitive Assessments Are More Important Among Adolescents Than Adults for Predicting Psychosis in Clinical High Risk
Zhang, T., Cui, H., Wei, Y., Tang, X., Xu, L., Hu, Y., Tang, Y., Chen, T., Li, C., & Wang, J. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.06.015 · Cited by 28
Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments
Lystad, J. U., Falkum, E., Haaland, V. Ø., Bull, H. C., Evensen, S., Bell, M. D., & Ueland, T. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.12.002 · Cited by 27
Plasma total antioxidant status and cognitive impairments in first-episode drug-naïve patients with schizophrenia
Xie, T., Li, Q., Luο, X., Tian, L., Wang, Z., Tan, S., Chen, S., Yang, G., An, H., Yang, F., et al. (2019) · Cognitive Neurodynamics · doi:10.1007/s11571-019-09530-3 · Cited by 27
Neurocognitive normality in schizophrenia revisited
Heinrichs, R. W., Pinnock, F., Muharib, E., Hartman, L. I., Goldberg, J. O., & Vaz, S. M. (2015) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2015.09.001 · Cited by 26
Screening for cognitive impairment in non-affective psychoses: A comparison between the SCIP and the MoCA
Murri, M. B., Folesani, F., Costa, S., Biancosino, B., Colla, C., Zerbinati, L., Caruso, R., Nanni, M. G., Purdon, S. E., & Grassi, L. G. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.01.005 · Cited by 26
MCCB cognitive profile in Spanish first episode schizophrenia patients
Rodríguez–Jiménez, R., Santos, J. L., Dompablo, M., Santabárbara, J., Aparicio, A. I., Olmos, R., Jiménez‐López, E., Sánchez‐Morla, E. M., Lobo, A., Palomo, T., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.07.011 · Cited by 25
Metamemory in schizophrenia: Retrospective confidence ratings interact with neurocognitive deficits
Eifler, S., Rausch, F., Schirmbeck, F. N., Veckenstedt, R., Mier, D. U., Esslinger, C., Englisch, S., Meyer‐Lindenberg, A., Kirsch, P., & Zink, M. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.040 · Cited by 24
Cognitive Impairments in Drug-Naive Patients With First-Episode Negative Symptom–Dominant Psychosis
Zhang, T., Wei, Y., Tang, X., Cui, H., Hu, Y., Xu, L., Liu, H., Wang, Z., Chen, T., Hu, Q., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.15110 · Cited by 25
Treating cognitive impairment in schizophrenia with GLP-1RAs: an overview of their therapeutic potential
Flintoff, J. M., Kesby, J. P., Siskind, D. J., & Burne, T. H. J. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1951702 · Cited by 25
Further evidence that antipsychotic medication does not prevent long-term psychosis in higher-risk individuals
Zhang, T., Wang, J., Xu, L., Wei, Y., Tang, X., Hu, Y., Cui, H., Tang, Y., Li, C., Zheng, L., et al. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01331-2 · Cited by 24
Examining neurocognition in body dysmorphic disorder using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): A comparison with obsessive-compulsive disorder
Toh, W. L., Castle, D. J., & Rossell, S. L. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.094 · Cited by 24
Relationship between social and cognitive functions in people with schizophrenia
Tominaga, T., Tomotake, M., Takeda, T., Ueoka, Y., Tanaka, T., Watanabe, S., Kameoka, N., Nakataki, M., Numata, S., Izaki, Y., et al. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s171207 · Cited by 23
Berberine improves negative symptoms and cognitive function in patients with chronic schizophrenia via anti-inflammatory effect: a randomized clinical trial
Pu, Z., Wen, H., Jiang, H., Hou, Q., & Yan, H. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00746-4 · Cited by 23

Authors: Kern, R. S., Gold, J. M., Dickinson, D., Green, M. F., Nuechterlein, K. H., Baade, L. E., Keefe, R. S. E., Mesholam-Gately, R. I., Seidman, L. J., Lee, C., Sugar, C. A., & Marder, S. R.
Affiliations: University of California, Los Angeles (US)
University of Maryland, Baltimore (US)
National Institutes of Health (US)
University of Kansas (US)
Duke University (US)
Beth Israel Deaconess Medical Center (US)
Corresponding author: Kern, Robert S.
ORCID: Kern, Robert S.
Gold, James M.
Dickinson, Dwight
Green, Michael F.
Nuechterlein, Keith H.
Baade, Lyle E.
Keefe, Richard S.E.
Seidman, Larry J.
Lee, Cathy
Sugar, Catherine A.
Marder, Stephen R.
Venue: Schizophrenia Research
Publisher: Elsevier BV
Published: 2011-03
Volume: 126
Issue: 1-3
Pages: 124-131
ISSN: 0920-9964 (ISSN-L)
DOI: 10.1016/j.schres.2010.11.008
PMC: PMC3050090
OpenAlex: W2128456675
Cited by: 251
References: 32
Citations by year: 2026: 9 · 2025: 17 · 2024: 14 · 2023: 13 · 2022: 16 · 2021: 23 · 2020: 24 · 2019: 20 · 2018: 20 · 2017: 14 · 2016: 10 · 2015: 24 · 2014: 18 · 2013: 12 · 2012: 6
FWCI: 6.34
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Schizophrenia Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (n01mh022006-001)
National Institute of Mental Health (N01 MH022006)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: schizophrenia, schizoaffective disorder
MeSH terms: Adolescent, Adult, Cognition Disorders, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Outpatients, Psychiatric Status Rating Scales, Psychometrics, Psychotic Disorders, Reference Values, Schizophrenia, Social Adjustment, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The MCCB impairment profile for schizophrenia outpatients: Results from the MATRICS psychometric and standardization study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks